Functional Neurologic Disorders, Vol 139. Handbook of Clinical Neurology

  • ID: 3084341
  • Book
  • 680 Pages
  • Elsevier Science and Technology
1 of 4

Functional Neurologic Disorders, the latest volume in the Handbook of Clinical Neurology series, summarizes state-of-the-art research findings and clinical practice on this class of disorders at the interface between neurology and psychiatry. This 51-chapter volume offers an historical introduction, chapters on epidemiology and pathophysiolology, a large section on the clinical features of different type of functional neurologic symptoms and disorders (including functional movement disorders, non-epileptic seizures, dizziness, vision, hearing, speech and cognitive symptoms), and then concluding with approaches to therapy.

This group of internationally acclaimed experts in neurology, psychiatry, and neuroscience represent a broad spectrum of areas of expertise, chosen for their ability to write clearly and concisely with an eye toward a clinical audience. This HCN volume sets a new landmark standard for a comprehensive, multi-authored work dealing with functional neurologic disorders (also described as psychogenic, dissociative or conversion disorders).

  • Offers a comprehensive interdisciplinary approach for the care of patients with functional disorders seen in neurologic practice, leading to more efficient prevention, management, and treatment
  • Provides a synthesis of research efforts incorporating clinical, brain imaging and neurophysiological studies
  • Fills an existing gap between traditional neurology and traditional psychiatry
  • Contents include coverage of history, epidemiology, clinical presentations, and therapy
  • Edited work with chapters authored by leaders in the field, the broadest, most expert coverage available
Note: Product cover images may vary from those shown
2 of 4

Section 1: History

Chapter 1: A brief history of hysteria: From the ancient to the modern

Chapter 2: Charcot, hysteria, and simulated disorders

Chapter 3: Neurologic approaches to hysteria, psychogenic and functional disorders from the late 19th century onwards

Chapter 4: Freud's hysteria and its legacy

Section 2: Epidemiology, etiology, and mechanism

Chapter 5: Epidemiology

Chapter 6: Neurophysiologic studies of functional neurologic disorders

Chapter 7: Imaging studies of functional neurologic disorders

Chapter 8: Dissociation and functional neurologic disorders

Chapter 9: Hypnosis as a model of functional neurologic disorders

Chapter 10: Psychologic theories in functional neurologic disorders

Chapter 11: Voluntary or involuntary? A neurophysiologic approach to functional movement disorders

Chapter 12: Neurobiologic theories of functional neurologic disorders

Chapter 13: Stress, childhood trauma, and cognitive functions in functional neurologic disorders

Chapter 14: Do (epi)genetics impact the brain in functional neurologic disorders?

Section 3: Symptoms (including signs and investigations)

Chapter 15: Assessment of patients with functional neurologic disorders

Chapter 16: The classification of conversion disorder (functional neurologic symptom disorder) in ICD and DSM

Chapter 17: Neurologic diagnostic criteria for functional neurologic disorders

Chapter 18: Functional limb weakness and paralysis

Chapter 19: Functional tremor

Chapter 20: Functional dystonia

Chapter 21: Functional jerks, tics, and paroxysmal movement disorders

Chapter 22: Psychogenic (functional) parkinsonism

Chapter 23: Functional gait disorder

Chapter 24: Functional sensory symptoms

Chapter 25: Nonepileptic seizures
subjective phenomena

Chapter 26: Nonepileptic seizures
objective phenomena

Chapter 27: Psychogenic nonepileptic seizures: EEG and investigation

Chapter 28: Functional coma

Chapter 29: Functional and simulated visual loss

Chapter 30: Functional eye movement disorders

Chapter 31: Functional facial and tongue movement disorders

Chapter 32: Functional auditory disorders

Chapter 33: Functional speech disorders: clinical manifestations, diagnosis, and management

Chapter 34: Functional voice disorders: Clinical presentations and differential diagnosis

Chapter 35: Psychologic/functional forms of memory disorder

Chapter 36: Functional (dissociative) retrograde amnesia

Chapter 37: Functional (psychogenic) dizziness

Chapter 38: Urologic symptoms and functional neurologic disorders

Chapter 39: Functional disorders of swallowing

Chapter 40: Pediatric functional neurologic symptoms

Chapter 41: Posttraumatic functional movement disorders

Chapter 42: Factitious disorders and malingering in relation to functional neurologic disorders

Section 4: Treatment

Chapter 43: Prognosis of functional neurologic disorders

Chapter 44: Explanation as treatment for functional neurologic disorders

Chapter 45: Physical treatment of functional neurologic disorders

Chapter 46: Psychologic treatment of functional neurologic disorders

Chapter 47: Hypnosis as therapy for functional neurologic disorders

Chapter 48: Nature of the placebo and nocebo effect in relation to functional neurologic disorders

Chapter 49: The role of placebo in the diagnosis and treatment of functional neurologic disorders

Chapter 50: Transcranial magnetic stimulation and sedation as treatment for functional neurologic disorders

Chapter 51: Inpatient treatment for functional neurologic disorders

Index

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Hallett, Mark
Dr. Hallett is the President of the International Federation of Clinical Neurophysiology. He also serves as the Chief of the Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland. Dr. Hallett obtained his M.D. at Harvard University, interned at the Peter Bent Brigham Hospital and trained in Neurology at Massachusetts General Hospital. He had fellowships in Neurophysiology at the National Institutes of Health and at the Institute of Psychiatry in London. From 1976 to 1984, Dr. Hallett was the Chief of the Clinical Neurophysiology Laboratory at the Brigham and Women's Hospital and worked up to Associate Professor of Neurology at Harvard Medical School. From 1984, he has been at the National Institute of Neurological Disorders and Stroke where he also served as Clinical Director of NINDS until July 2000. He is past President of the American Association of Neuromuscular and Electrodiagnostic Medicine and the International Parkinson and Movement Disorder Society and also served as Vice-President of the American Academy of Neurology. He has served as Editor of many journals and books and has had many honors. His work mainly deals with principles of motor control and the pathophysiology of movement disorders. Dr. Hallett's interests in motor control are wide-ranging, and include brain plasticity and its relevance to neurological disorders and the pathophysiology of dystonia, parkinsonism, and myoclonus. In recent years, he has become interested in disorders of volition, including tic and functional movement disorders.
Stone, Jon
Carson, Alan J
Name: Alan John Carson
Qualifications: MBCHB, MPHIL, MD, FRCPSYCH, FRCP
Post: Consultant Neuropsychiatrist, Edinburgh
My interest in neuropsychiatry began during a spell working in Kenya, as a Wellcome Research Registrar, conducting a study on the psychiatric and cognitive effects of HIV infection. I then completed my higher training in Edinburgh, under the guidance of Professors Michael Sharpe and Charles Warlow, where I developed an interest in functional neurological symptoms. I currently work as a Consultant Neuropsychiatrist in Edinburgh split between the brain injury units at the Astley Ainslie Hospital and the Regional Neurosciences Unit at the Western General Hospital, where along with Dr Jon Stone, I am engaged in a series of studies on functional neurological symptoms. I have led a number of epidemiological studies on functional disorders, most notably the Scottish Neurological Symptoms Study. I have a particular interest in development of treatment strategies for functional disorders and have led development of novel brief psychotherapies for functional symptoms and am one of the lead investigators for the CODES trial of CBT for dissociative seizures. I hold a number of advisory posts in neuropsychiatry and I am the chair of the National MCN for acquired brain injury. I am the associate editor of Journal of Neurology, Neurosurgery and Psychiatry and the President of the British Neuropsychiatry Association.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll